Drug Side Effects
Search
LI-FRAUMENI SYNDROME
LI-FRAUMENI SYNDROME
was reported 16 times
LI-FRAUMENI SYNDROME is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
CD33-directed Immunoconjugate [EPC]
2
0.0005
1
Cannabinoid [EPC]
1
0.0001
2
Topoisomerase Inhibitor [EPC]
7
0.0001
3
BCL-2 Inhibitor [EPC]
5
0.0001
4
Anticholinergic [EPC]
1
0.0001
5
Recombinant Human Growth Hormone [EPC]
1
0.0000
6
Alkylating Drug [EPC]
8
0.0000
7
Proteasome Inhibitor [EPC]
3
0.0000
8
Peroxisome Proliferator Receptor alpha Agonist [EPC]
1
0.0000
9
Platinum-based Drug [EPC]
4
0.0000
10
Nucleoside Metabolic Inhibitor [EPC]
4
0.0000
11
HER2/neu Receptor Antagonist [EPC]
1
0.0000
12
Azole Antifungal [EPC]
2
0.0000
13
Acetylcholine Release Inhibitor [EPC]
1
0.0000
14
Antirheumatic Agent [EPC]
1
0.0000
15
Serotonin-3 Receptor Antagonist [EPC]
1
0.0000
16
alpha-Adrenergic Blocker [EPC]
1
0.0000
17
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
18
Microtubule Inhibitor [EPC]
1
0.0000
19
Thalidomide Analog [EPC]
3
0.0000
20
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
21
Corticosteroid [EPC]
5
0.0000
22
beta-Adrenergic Blocker [EPC]
1
0.0000
23
Insulin Analog [EPC]
1
0.0000
24
Kinase Inhibitor [EPC]
1
0.0000
25
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000
26
Benzodiazepine [EPC]
1
0.0000